68
|
240
|
5dkiC |
Yeast 20s proteasome in complex with alkyne-pi |
59
|
222
|
5d0zH |
Yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib |
57
|
204
|
5d0xI |
Yeast 20s proteasome beta5-t1s mutant in complex with bortezomib |
57
|
204
|
5dkiI |
Yeast 20s proteasome in complex with alkyne-pi |
68
|
212
|
5dkjK |
Yeast 20s proteasome in complex with octreotide-pi |
70
|
244
|
5dkiB |
Yeast 20s proteasome in complex with alkyne-pi |
65
|
250
|
5dkjA |
Yeast 20s proteasome in complex with octreotide-pi |
62
|
231
|
5dkiE |
Yeast 20s proteasome in complex with alkyne-pi |
59
|
226
|
5dkiH |
Yeast 20s proteasome in complex with alkyne-pi |
60
|
226
|
5dkjH |
Yeast 20s proteasome in complex with octreotide-pi |
60
|
222
|
5dkjL |
Yeast 20s proteasome in complex with octreotide-pi |
66
|
212
|
5dkiK |
Yeast 20s proteasome in complex with alkyne-pi |
62
|
195
|
5dkjJ |
Yeast 20s proteasome in complex with octreotide-pi |
70
|
243
|
5dkjF |
Yeast 20s proteasome in complex with octreotide-pi |
70
|
229
|
5czaM |
Yeast 20s proteasome beta5-d166n mutant |
69
|
244
|
5cz8B |
Yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib |
61
|
196
|
5d0wN |
Yeast 20s proteasome beta5-t1s mutant |
68
|
250
|
5d0zA |
Yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib |
87
|
294
|
4zo3A |
Aidc, a dizinc quorum-quenching lactonase, in complex with a product n-hexnoyl-l-homoserine |
80
|
225
|
4ysbA |
Crystal structure of ethe1 from myxococcus xanthus |
67
|
244
|
5cz9B |
Yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans |
68
|
240
|
5d0tC |
Yeast 20s proteasome beta5-d166n mutant in complex with mg132 |
59
|
226
|
5d0xH |
Yeast 20s proteasome beta5-t1s mutant in complex with bortezomib |
69
|
229
|
5cz4M |
Yeast 20s proteasome at 2.3 a resolution |
68
|
242
|
5czaD |
Yeast 20s proteasome beta5-d166n mutant |
68
|
250
|
5czaA |
Yeast 20s proteasome beta5-d166n mutant |
72
|
244
|
5d0wB |
Yeast 20s proteasome beta5-t1s mutant |
68
|
250
|
5d0wA |
Yeast 20s proteasome beta5-t1s mutant |
62
|
241
|
5cz5G |
Yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib |
67
|
242
|
5cz8D |
Yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib |
62
|
231
|
5cz5E |
Yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib |
60
|
196
|
5d0vN |
Yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib |
73
|
240
|
5d0wC |
Yeast 20s proteasome beta5-t1s mutant |
63
|
231
|
5d0xE |
Yeast 20s proteasome beta5-t1s mutant in complex with bortezomib |
159
|
509
|
5cwaA |
Structure of anthranilate synthase component i (trpe) from mycobacterium tuberculosis with inhibitor bound |
62
|
196
|
5cz6N |
Yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans |
57
|
204
|
5czaI |
Yeast 20s proteasome beta5-d166n mutant |
71
|
243
|
5d0sF |
Yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib |
71
|
218
|
5d0vK |
Yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib |
65
|
242
|
5d0zD |
Yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib |
59
|
196
|
5ahjN |
Yeast 20s proteasome in complex with macyranone a |
61
|
222
|
5cz7L |
Yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis |
59
|
222
|
5cz8L |
Yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib |
57
|
204
|
5cz8I |
Yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib |
70
|
243
|
5d0tF |
Yeast 20s proteasome beta5-d166n mutant in complex with mg132 |
68
|
244
|
5d0zB |
Yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib |
69
|
212
|
5ahjK |
Yeast 20s proteasome in complex with macyranone a |
70
|
233
|
5cz6M |
Yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans |
63
|
241
|
5cz4G |
Yeast 20s proteasome at 2.3 a resolution |
67
|
250
|
5cz6A |
Yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans |